Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids

• Published in: Emerging infectious diseases Vol. 28; no. 7; pp. 1531 - 1533
• Main Authors: Kim, Jani M., Sivasubramanian, Geetha
• Format: Journal Article
• Language: English
• Published: United States U.S. National Center for Infectious Diseases 01.07.2022; Centers for Disease Control and Prevention
• Subjects: Adrenal Cortex Hormones - therapeutic use; Animals; Case studies; Complications and side effects; Coronaviruses; Corticosteroids; COVID-19; COVID-19 Drug Treatment; Disease transmission; Fever; Humans; Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids; Infections; Lavage; Parasites; Patients; Pneumonia; Research Letter; respiratory infections; Risk factors; Severe acute respiratory syndrome coronavirus 2; Steroids; Strongyloides; Strongyloides stercoralis; Strongyloidiasis; Strongyloidiasis - diagnosis; Strongyloidiasis - drug therapy; Strongyloidiasis - epidemiology; Syndrome; Tomography; Tropical diseases; United States; United States > US; San Francisco California; California; COVID-19; SARS-CoV-2; viruses; severe acute respiratory syndrome coronavirus 2; Strongyloides stercoralis; SARS; coronavirus; parasites; zoonoses; coronavirus disease; Strongyloides; respiratory infections
• ISSN: 1080-6040; 1080-6059; 1080-6059
• DOI: 10.3201/eid2807.220198

Widespread use of corticosteroids for COVID-19 treatment has led to Strongyloides reactivation and severe disease in patients from endemic areas. We describe a US patient with COVID-19 and Strongyloides hyperinfection syndrome and review other reported cases. Our findings highlight the need for Strongyloides screening and treatment in high-risk populations.